Urteste S.A. (WSE:URT)
Poland
· Delayed Price · Currency is PLN 50.00
+1.00 (2.04%)
Mar 9, 2026, 4:05 PM CET
Urteste Company Description
Urteste S.A. engages in the research and development of diagnostic tests for cancers.
It offers diagnostic tests for pancreas, prostate, kidney, colon, liver, biliary tract, bile ducts, stomach, lung, esophagus, ovary, endometrium, blood, breast, and brain.
The company was incorporated in 2021 and is based in Gdańsk, Poland.
Urteste S.A.
| Country | Poland |
| Founded | 2021 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 36 |
| CEO | Grzegorz Stefanski |
Contact Details
Address: ul. Starodworska 1 Gdansk, 80-137 Poland | |
| Website | urteste.eu |
Stock Details
| Ticker Symbol | URT |
| Exchange | Warsaw Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | PLN |
| ISIN Number | PLURTST00010 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Grzegorz Stefanski | President of the Management Board |
| Tomasz Kostuch | Member of the Management Board |